Prothrombinase induced clotting time (PiCT®) for measuring the activity of direct factor Xa inhibitors in clinical setting

被引：0
|
作者：
Olivera, P. E. [1 ]
Cortina, V [1 ]
Pons, V [1 ]
Merchan, B. [2 ]
Lopez-Andreoni, L. [1 ]
Artaza, G. [1 ]
Menino, E. [3 ]
Marin, A. [2 ]
Bosch, F. [2 ]
Santamaria, A. [1 ]
机构：
[1] Univ Hosp Vall dHebron, Hemostasis & Thrombosis Unit, Barcelona, Spain
[2] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain
[3] Primary Healthcare Ctr Rio de Janeiro Prosperitat, Barcelona, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO375-TUE
引用
收藏
页码：643 / 643
页数：1
相关论文
共 50 条
  • [41] Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can be Used for the Monitoring of Anti-Xa Agents in Whole Blood and Plasma
    Hoppensteadt, Debra
    Bontekoe, Emily
    Siddiqui, Fakiha
    Farooqui, Ambar
    Iqbal, Omer
    Jeske, Walter
    Walenga, Jeanine
    Tafur, Alfonso J.
    Fareed, Jawed
    BLOOD, 2019, 134
  • [42] Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial
    Hamulyak, Eva N.
    Wiegers, Hanke M. G.
    Hutten, Barbara A.
    de Lange, Maria E.
    Timmermans, Anne
    Westerweel, Peter E.
    Nijziel, Marten R.
    Klok, Frederikus A.
    Hovens, Marcel M.
    Kamphuisen, Pieter W.
    Buller, Harry R.
    Middeldorp, Saskia
    Scheres, Luuk J. J.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [43] Distribution of Anti-Factor Xa Activity Value, Prothrombin Time, and Activated Partial Thromboplastin Time in Patients Treated With Factor Xa Inhibitors
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    CIRCULATION, 2022, 146
  • [44] CORRELATION OF ANTI-FACTOR XA ACTIVITY VALUE, PROTHROMBIN TIME, AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS TREATED WITH FACTOR XA INHIBITORS
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2109 - 2109
  • [45] Anti-Xa Activity and Event Risk in Patients With Direct Factor Xa Inhibitors Initiated Early After Stroke
    Wada, Shinichi
    Toyoda, Kazunori
    Sato, Shoichiro
    Matsuki, Takayuki
    Okata, Takuya
    Kumamoto, Masaya
    Tagawa, Naoki
    Inoue, Manabu
    Okamoto, Akira
    Ihara, Masafumi
    Kitazono, Takanari
    Miyata, Toshiyuki
    Koga, Masatoshi
    CIRCULATION JOURNAL, 2018, 82 (11) : 2872 - +
  • [46] Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
    Perzborn, E.
    Heitmeier, S.
    Buetehorn, U.
    Laux, V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (07) : 1054 - 1065
  • [47] ANTICOAGULANT ACTIVITY OF DIRECT FACTOR XA INHIBITORS AS A TOOL TO ENSURE THE EFFECTIVENESS AND SAFETY OF DRUGS INTAKE
    Vavilova, T. V.
    KARDIOLOGIYA, 2019, 59 (11) : 28 - 35
  • [48] A Novel Prothrombin Time Assay for Assessing the Anticoagulant Activity of Oral Factor Xa Inhibitors
    Barrett, Yu Chen
    Wang, Zhaoqing
    Knabb, Robert M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (05) : 522 - 528
  • [49] Comparison of direct factor XA inhibitor YM150 with other oral FXA inhibitors on prothrombin time clotting tests using commercially available thromboplastin reagents
    Funatsu, T.
    Iwatsuki, Y.
    Kaku, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 110 - 110
  • [50] The distribution of anti-factor Xa activity value, PT and APTT at peak and trough times in patients with direct anti-factor Xa inhibitors
    Ono, R.
    Fukushima, K.
    Yamazaki, T.
    Takahashi, H.
    Hori, Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3368 - 3368
12345